This weekly feature from Dynamic Business runs down the week’s top funding rounds from Australia and the US. Check out last week’s biggest funding rounds here.
Tic:Toc closes $54m Series D funding round
Australian platform technology company Tic:Toc has announced the completion of its Series D2 funding round, raising AUD$24 million in strategic investment led by existing shareholder IAG Firemark Ventures.
This follows the AUD$30 million Series D round committed in February 2022, also led by IAG Firemark Ventures. The funding will be used to enable Tic:Toc to integrate additional products and services, such as insurance, into its platform and provide seamless customer experiences. Bendigo and Adelaide Bank also invested in both the initial and follow-on Series D rounds.
Vively raises $1.5 million in pre-Seed to tackle blood sugar levels
Metabolic wellness platform Vively has raised $1.5 million in an oversubscribed pre-seed funding round led by Archangel Ventures. Vively’s technology uses continuous glucose monitoring through an arm patch to help users understand the impact of their diet and lifestyle on their metabolic health in real time.
Sydney solar startup 5B bags $55 million in Series B
BP Ventures, the venture capital arm of energy company BP, has invested $20 million in Sydney solar startup 5B as part of the company’s $55 million Series B funding round. This follows the initial $30 million raised in June, led by existing investors AES Corporation and Artesian Venture, who also contributed an additional $5 million in the latest funding round. Other investors in 5B include former prime minister Malcolm Turnbull and climate campaigner Simon Holmes à Court.
Rest of the world
Insider raises $121 million to help companies analyze marketing data
Marketing is becoming more data-driven in a world that does an increasing amount of its business online. Nearly one-third of marketers say they have a strategy planned to unify their disparate marketing data. Insider last week raised $121 million in a series D funding round at a $1.22 billion post-money valuation.
Linse Capital Raises $700 million To Back Industrial Technology Companies
Linse Capital raised $700m to back industrial technology companies. LPs include affiliates of Oppenheimer & Co., Daimler Truck, Taiwan Mobile and a syndicate of more than 400 family offices and high-net-worth individuals. The firm aims to become the largest or one of the largest shareholders at exit.
Enlaza Therapeutics Raises $61 million in seed financing
Enlaza Therapeutics, a La Jolla, CA-based covalent biologic company, raised $61M in Seed financing. The round was led by Avalon Ventures, with participation from Lightspeed Venture Partners, Frazier Life Sciences, and Samsara BioCapital. The company intends to use the funds to advance its proprietary War-Lock platform.
Keep up to date with our stories on LinkedIn, Twitter, Facebook and Instagram.
